Literature DB >> 1493977

Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus.

T H Farmer1, J Gilbart, S W Elson.   

Abstract

Twenty one strains of Staphylococcus aureus, of varying resistance to mupirocin, were examined in order to determine the mechanism of resistance to this antibiotic; six of these strains were mupirocin sensitive (MIC 0.12-1.0 mg/L) nine moderately resistant strains (MIC 8-256 mg/L) and six highly resistant strains (MIC > 2048 mg/L). Mupirocin showed a time-dependent inhibition of the target enzyme, isoleucyl-tRNA synthetase (IRS); incubation of the antibiotic with this enzyme before adding the substrates markedly increased inhibition in sensitive strains. The IRS I50 values (the antibiotic concentrations which cause a 50% decrease in enzyme activity) correlated well with the MIC values for each strain (P < 0.01). The mean I50 value for sensitive strains was 3.3 x 10(-2) mg/L, in moderately resistant strains it was 1.3 x 10(-1) mg/L and in highly resistant strains it was 7.5 mg/L. No degradation of mupirocin could be detected during extended incubation of the antibiotic with cell free extracts from four resistant S. aureus strains. We conclude that the production of a modified IRS enzyme is the major cause of mupirocin resistance in the strains studied.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493977     DOI: 10.1093/jac/30.5.587

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Mupirocin - Are we in danger of losing it?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-05

4.  Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.

Authors:  Urs A Ochsner; Casey L Young; Kimberley C Stone; Frank B Dean; Nebojsa Janjic; Ian A Critchley
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Authors:  Stephanie A Fritz; Patrick G Hogan; Bernard C Camins; Ali J Ainsworth; Carol Patrick; Madeline S Martin; Melissa J Krauss; Marcela Rodriguez; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus.

Authors:  Martin Antonio; Neil McFerran; Mark J Pallen
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

7.  Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.

Authors:  Adriana Cadilla; Michael Z David; Robert S Daum; Susan Boyle-Vavra
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

Review 8.  Resistance to and synthesis of the antibiotic mupirocin.

Authors:  Christopher M Thomas; Joanne Hothersall; Christine L Willis; Thomas J Simpson
Journal:  Nat Rev Microbiol       Date:  2010-03-01       Impact factor: 60.633

9.  New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci.

Authors:  Kunyan Zhang; Jennifer Sparling; Barbara L Chow; Sameer Elsayed; Zafar Hussain; Deirdre L Church; Daniel B Gregson; Thomas Louie; John M Conly
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

10.  SB 205952, a novel semisynthetic monic acid analog with at least two modes of action.

Authors:  J M Wilson; B Oliva; R Cassels; P J O'Hanlon; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.